HUTCHMED (LON:HCM) Share Price Passes Below 200-Day Moving Average - Here's Why

Key Points

• HUTCHMED shares fell below their 200-day moving average, trading as low as GBX 194 and last at GBX 196 (the 200-day MA is GBX 215.64), down about 0.3% on volume of 11,292 shares.
• The stock shows mixed fundamentals with a market capitalization of £1.68 billion and a low P/E of 3.69, but notable leverage (debt-to-equity of 7.91) alongside strong liquidity (current ratio 4.96).
• HUTCHMED is a China-focused novel oncology drug developer with approved medicines and commercial operations in China, and is listed on Nasdaq, the Hong Kong Stock Exchange and the London AIM market.

HUTCHMED (China) Limited (LON:HCM - )'s share price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 215.64 and traded as low as GBX 194. HUTCHMED shares last traded at GBX 196, with a volume of 11,292 shares.

HUTCHMED Trading Down 0.3%

The company has a debt-to-equity ratio of 7.91, a current ratio of 4.96 and a quick ratio of 2.97. The business has a 50 day moving average of GBX 212.08 and a 200 day moving average of GBX 215.64. The firm has a market capitalization of £1.68 billion, a price-to-earnings ratio of 3.69 and a beta of 0.45.

About HUTCHMED

We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capabilities. Since inception, we have focused on bringing cancer drug candidates from in-house discovery to patients around the world, with our first three oncology medicines now approved marketed in China, the first of which is also marketed in the U.S. We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes our novel oncology products, as well as prescription drugs and consumer health products in China. HUTCHMED is listed on the Nasdaq Global Select Market, the Stock Exchange of Hong Kong Limited and the London Stock Exchange's AIM market (Nasdaq/AIM:HCM; HKEX:13).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.